共查询到17条相似文献,搜索用时 78 毫秒
1.
2.
3.
4.
丙酮酸脱氢酶系(pyruvate dehydrogenase,PDH)是一个有潜力的除草剂作用靶点。采用不同取代苯甲醛合成各种α-羟基芳基膦酸酯,然后与2,6-吡啶二甲酰氯反应得到五个不同取代基的2,6-吡啶二甲酰氧基烃基膦酸酯,并由IR与1H NMR波谱进行验证。进一步通过对比分析各个不同产物的产率得出苯甲醛上不同取代基对此反应的影响。 相似文献
5.
6.
构建了人丙酮酸羧化酶(hPC)异位表达的重组CHO细胞,并检测了重组细胞生长情况的改变。利用分子生物学实验技术构建hPC-pcDNA 3.0表达载体,将其转染CHO-K1细胞;转染细胞经过G418抗性筛选后,通过荧光定量PCR检测目的基因表达,并挑选表达量最高的克隆进行补料分批培养。电泳及测序结果显示,构建的hPC-pcDNA3.0表达载体序列与预期一致;在mRNA水平鉴定目的基因显示,4#克隆的mRNA表达水平最高;选其进行补料分批培养,生长曲线显示在培养后期,其活细胞密度和细胞活率均高于对照。成功构建了细胞生长和活率改善的重组CHO细胞,获得了生长改善的细胞株,为后续的重组蛋白表达研究与细胞培养工艺优化奠定了基础。 相似文献
7.
8.
9.
10.
11.
12.
Pyruvate dehydrogenase kinases (PDKs) are key enzymes in glucose metabolism, negatively regulating pyruvate dehyrogenase complex (PDC) activity through phosphorylation. Inhibiting PDKs could upregulate PDC activity and drive cells into more aerobic metabolism. Therefore, PDKs are potential targets for metabolism related diseases, such as cancers and diabetes. In this study, a series of computer-aided virtual screening techniques were utilized to discover potential inhibitors of PDKs. Structure-based screening using Libdock was carried out following by ADME (adsorption, distribution, metabolism, excretion) and toxicity prediction. Molecular docking was used to analyze the binding mechanism between these compounds and PDKs. Molecular dynamic simulation was utilized to confirm the stability of potential compound binding. From the computational results, two novel natural coumarins compounds (ZINC12296427 and ZINC12389251) from the ZINC database were found binding to PDKs with favorable interaction energy and predicted to be non-toxic. Our study provide valuable information of PDK-coumarins binding mechanisms in PDK inhibitor-based drug discovery. 相似文献
13.
14.
Artem V. Artiukhov Vasily A. Aleshin Irina S. Karlina Alexey V. Kazantsev Daria A. Sibiryakina Alexander L. Ksenofontov Nikolay V. Lukashev Anastasia V. Graf Victoria I. Bunik 《International journal of molecular sciences》2022,23(21)
Mitochondrial pyruvate dehydrogenase complex (PDHC) is essential for brain glucose and neurotransmitter metabolism, which is dysregulated in many pathologies. Using specific inhibitors of PDHC in vivo, we determine biochemical and physiological responses to PDHC dysfunction. Dose dependence of the responses to membrane-permeable dimethyl acetylphosphonate (AcPMe2) is non-monotonous. Primary decreases in glutathione and its redox potential, methionine, and ethanolamine are alleviated with increasing PDHC inhibition, the alleviation accompanied by physiological changes. A comparison of 39 brain biochemical parameters after administration of four phosphinate and phosphonate analogs of pyruvate at a fixed dose of 0.1 mmol/kg reveals no primary, but secondary changes, such as activation of 2-oxoglutarate dehydrogenase complex (OGDHC) and decreased levels of glutamate, isoleucine and leucine. The accompanying decreases in freezing time are most pronounced after administration of methyl acetylphosphinate and dimethyl acetylphosphonate. The PDHC inhibitors do not significantly change the levels of PDHA1 expression and phosphorylation, sirtuin 3 and total protein acetylation, but increase total protein succinylation and glutarylation, affecting sirtuin 5 expression. Thus, decreased production of the tricarboxylic acid cycle substrate acetyl-CoA by inhibited PDHC is compensated by increased degradation of amino acids through the activated OGDHC, increasing total protein succinylation/glutarylation. Simultaneously, parasympathetic activity and anxiety indicators decrease. 相似文献
15.
16.